Cipriani Fiammetta, Gnessi Lucio, Watanabe Mikiko, Baldelli Roberto
Section of Medical Pathophysiology, Food Science and Endocrinology, Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.
Endocrinology Unit, Department of Oncology and Medical Specialties, A.O. San Camillo-Forlanini, 00152 Rome, Italy.
Nutrients. 2025 Jun 13;17(12):1999. doi: 10.3390/nu17121999.
The mechanisms underlying the disruption of bone balance are well known. To date, several possible treatments exist for osteoporosis, mostly based on inhibition of bone resorption. However, as osteoporosis is a disease that causes significant fragility, it merits a proactive prevention-based approach, which identifies risk factors, such as nutritional deficiencies, during the preosteoporotic stage. In this context, nutraceuticals may find application in delaying the onset of osteoporosis and prior to the need for pharmaceutical invention. The beneficial effects of inositol supplementation have been extensively studied in endocrinology and gynecology; herein, we discuss the potential of inositols in the prevention of osteoporosis, highlighting the link with bone metabolism and possible future applications.
骨骼平衡破坏的潜在机制已为人熟知。迄今为止,针对骨质疏松症有几种可能的治疗方法,大多基于抑制骨吸收。然而,由于骨质疏松症是一种会导致严重骨质脆弱的疾病,它值得采取一种基于主动预防的方法,即在骨质疏松前期识别诸如营养缺乏等风险因素。在此背景下,营养保健品可能在延缓骨质疏松症发病以及在需要药物干预之前找到应用。肌醇补充剂的有益作用在内分泌学和妇科领域已得到广泛研究;在此,我们讨论肌醇在预防骨质疏松症方面的潜力,强调其与骨代谢的联系以及可能的未来应用。